AI industry faces public skepticism despite medical breakthroughs in rare disease diagnosis

Aug 15, 2026

While artificial intelligence tools like Face2Gene are successfully resolving long-standing medical mysteries for rare disease patients, the AI industry faces a deepening public relations crisis. Recent polling indicates that 52% of Americans feel more concerned than excited about AI, and over 70% believe development is moving too quickly. In response, Anthropic CEO Dario Amodei admits that AI firms have failed to deliver on their grand promises, arguing that the industry must achieve major breakthroughs, like curing cancer, to rebuild public trust.

Public skepticism toward AI

▪A May 2026 Economist/YouGov poll found that over 70% of Americans believe artificial intelligence development is moving too quickly.
▪A CNBC poll of 18- to 34-year-olds in August 2026 found that a majority of respondents do not trust nine named top AI industry leaders to act responsibly regarding AI.
▪A Pew Research Center study released in August 2026 found that 52% of Americans feel "more concerned than excited" about the increased use of AI in daily life, up from 37% in 2021.

AI industry public relations crisis

▪Airbnb CEO Brian Chesky stated on a podcast that the AI backlash is real and is largely tied to the industry failing to ship products that regular people like and can use.
▪OpenAI applied AI architect Angel Brodin stated that the public will judge AI companies by pricing, access, lobbying, opacity, and the distribution of economic gains rather than solely by their breakthroughs.
▪Tech companies are facing a public relations crisis over plans to build AI data centers across the United States, prompting them to offer job guarantees, clean water investments, and local perks to appease communities.

Rare disease diagnosis using AI

▪Patients with rare diseases often spend five years or more searching for a diagnosis, a timeline that artificial intelligence is now helping to accelerate.
▪An AI-assisted app called Face2Gene uses facial analysis to help healthcare professionals flag rare genetic disorders, which helped diagnose a 10-year-old boy and his mother with Trichorhinophalangeal syndrome.

Anthropic CEO on AI criticism

▪Anthropic CEO Dario Amodei stated in an August 2026 post on X that the most accurate criticism of AI companies is that they have not yet delivered on big promises to benefit the world.
▪Yann LeCun, the former chief AI scientist at Meta, argued that keeping frontier AI technology closed-source, as Anthropic does, contributes significantly to public distrust of AI.
▪Anthropic CEO Dario Amodei argued that the best way to win over AI skeptics and improve public opinion is for the AI industry to deliver tangible scientific breakthroughs, such as actually curing cancer.

Data center community opposition

▪The National Republican Senatorial Committee sent a memo to top AI companies warning that U.S. data centers are hurting the party's chances in a key Ohio election.
▪The AI industry is facing public backlash as it builds massive data centers in communities across the United States, which has begun to affect tech companies' balance sheets.